Anavex Life Sciences AVXL
NASDAQ AVXL
$1.06 -0.07 (-6.19%)
At close: Nov 11, 2026 · 4:00 PM EST

Anavex Life Sciences (AVXL) Share-based Compensation (IS) (2015 - 2021)

Updated

Analysis

Anavex Life Sciences (AVXL) Share-based Compensation (IS) (2015 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Anavex Life Sciences 104.75 Mn -375.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 3.91 Mn
Sep 30, 2021 10.45 Mn
Dec 31, 2020 939,314.00
Sep 30, 2020 8.28 Mn
Dec 31, 2019 6.57 Mn
Dec 31, 2015 2.29 Mn
API Access

Anavex Life Sciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=AVXL&period=max&api_key=YOUR_API_KEY